ZimVie Inc. (ZIMV)
13.79
0.32 (2.38%)
At close: Jan 15, 2025, 1:16 PM
undefined% (undefined)
| Bid | 13.77 |
| Market Cap | 380.59M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.77 |
| PE Ratio (ttm) | -7.79 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 13.8 |
| Volume | 20,441 |
| Avg. Volume (20D) | 138,321 |
| Open | 13.88 |
| Previous Close | 13.47 |
| Day's Range | 13.69 - 13.88 |
| 52-Week Range | 13.01 - 22.40 |
| Beta | undefined |
About ZIMV
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and vir...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 2022
Employees 2,600
Stock Exchange NASDAQ
Ticker Symbol ZIMV
Website https://www.zimvie.com
Analyst Forecast
According to 2 analyst ratings, the average rating for ZIMV stock is "Strong Buy." The 12-month stock price forecast is $19.5, which is an increase of 41.41% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 50.00%
Next Earnings Release
ZimVie Inc. is scheduled to release its earnings on Feb 26, 2025,
during market hours.
Analysts project revenue of $115.70M, reflecting a 2.33% YoY growth and earnings per share of 0.27, making a 170.00% increase YoY.
Analysts project revenue of $115.70M, reflecting a 2.33% YoY growth and earnings per share of 0.27, making a 170.00% increase YoY.
5 months ago ·
Source
-15.2%
ZimVie shares are trading lower after the company ...
Unlock content with
Pro Subscription
6 months ago ·
Source
+22.72%
ZimVie shares are trading higher following a report suggesting that the company is considering a potential sale.
